Table 3. Cox regression analysis of PFS in patients with lung adenocarcinoma.
| eβ | SE | P value | β | |
|---|---|---|---|---|
| LPA | 0.028 | 0.013 | 0.034 | 1.029 |
Model χ2:4.527 (P=0.041). PFS, progression-free survival; LPA, lysophosphatidic acid; β, regression coefficient; SE, standard error; eβ, HR (hazard ratio).